On the other hand, CXCR4 activation triggered VEGF-dependent neoangiogenesis in glioma and breast cancer cells, suggesting that CXCL12 may synergize with other pro-angiogenic factors to induce the formation of new blood vessels [170,171]. Here, CXCL12 is linked to breast cancer.